Neuroscience News at Yale

Strittmatter is being recognized for making great strides toward reversing spinal cord injury.

Marina Picciotto, PhD, Deputy Chair for Basic Science and Charles B.G. Murphy Professor of Psychiatry, of Neuroscience, of Pharmacology and in the Child Study Center, has been named Director of the Ribicoff Labs and of the Division of Molecular Psychiatry. Christopher Pittenger, MD, PhD, Professor of Psychiatry, Assistant Chair for Translational Research, and Director of the Yale OCD Research Clinic, has been named Director of the Clinical Neuroscience Research Unit (CNRU) and of the Neuroscience Research Training Program (NRTP).

Yale researchers describe a specific neuron that appears to play an important role in whether anorexia becomes deadly. They also discovered a potential treatment: a high-fat diet.

Two Yale research teams will each receive approximately $9 million in grants from the Aligning Sciences Across Parkinson’s (ASAP) initiative to study the underlying biology of Parkinson’s disease.

Yale researchers in the lab of Joerg Bewersdorf have developed a way to visualize extremely tiny structures by using standard light microscopy, a world previously only accessible by expensive and cumbersome electron microscopy.

The two Yale research projects involve the role of mitochondria, the cell’s energy producing factories, in the onset of disease.

A National Science Foundation (NSF) grant has been made to an international team of scientists headed by Yale neuroscientist Amy Arnsten.

Principal Investigators Serena Spudich, MD, MA (Neurology), Mark Gerstein, PhD (Molecular Biophysics and Biochemistry), and Yuval Kluger, PhD (Pathology) were recently awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to establish a Data Center to coordinate, analyze, and make accessible single-cell and other molecular data sets generated by Single-Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects.

Since June 1, the start of a broad, three-phase reactivation of campus, an estimated 4,000 faculty members, graduate students, and staff representing more than 500 labs around Yale have fired up microscopes, opened fume hoods, or dusted off other essential research equipment.